3 DZHK (German Centre for Cardiovascular Research), Berlin, Germany. dominik.mueller@mdc-berlin.de.
4 Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
5 VIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research (IRC), Hasselt University, Diepenbeek, Belgium. markus.kleinewietfeld@uhasselt.vib.be.
6 Department of Immunology, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium. markus.kleinewietfeld@uhasselt.vib.be.
7 University Multiple Sclerosis Center (UMSC), Hasselt University, Diepenbeek, Belgium. markus.kleinewietfeld@uhasselt.vib.be.
8 Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg and University of Regensburg, Regensburg, Germany. jonathan.jantsch@uk-koeln.de.
9 Institute for Medical Microbiology, Immunology, and Hygiene, and Center for Molecular Medicine Cologne (CMMC), University Hospital Cologne and Faculty of Medicine, University of Cologne, Cologne, Germany. jonathan.jantsch@uk-koeln.de.